A 50 bp DNA ladder was used as a marker on the gel. The PCR product profiles were visualized using
the participants’ in-house method and electronic images were sent to NIBSC for collation and analysis. The cultural viable count assay was used to monitor the thermal stability of the live BCG vaccine preparation and was performed at NIBSC only. An accelerated degradation study was not used for this live preparation as incubation temperatures greater than 37 °C for a period longer than 4 weeks can kill most of the live bacilli in the preparation. A slightly modified method used for temperature stability, as stated in both WHO Recommendations  and European Pharmacopoeia monograph for BCG vaccine, freeze-dried  was used instead to determine the thermal stability of the lyophilized BCG vaccine preparation. Five ampoules each of the BCG Moreau-RJ preparation were DAPT incubated at 4 °C or 37 °C for a period of 4 weeks prior to performing the cultural viable count assay. These results were then compared with those from ampoules stored at −20 °C as recommended storage temperature for this preparation. Real-time stability study is performed by NIBSC. The viability in terms of CFUs in cultural viable count assay of all four Reference Reagents
of BCG vaccine stored at −20 °C, will be monitored for 10 years of shelf life annually to ensure the viability of these Reference Reagents is maintained within the acceptable range (as estimated from collaborative studies) at time of distribution. All of the results Veliparib solubility dmso from the cultural viable count assay were converted to CFU per ampoule. The mean CFU per ampoule was calculated from the mean estimates of the colony counts of each dilution  following the WHO/TB/Technical Guide/77.9 (in vitro assays of BCG products, unpublished working document
in 1977). The choice of formula reflects the appropriate weight given to the number of colonies counted for a test BCG sample at each dilution already level. Any of the ampoules within a laboratory’s results that were found to be outliers using an in-house program  and Grubbs’ test  were excluded from further statistical analysis. For the modified ATP assays, standard curves were generated by linear regression of log10 light emission reading (response) on log10 concentration of ATP standard. Responses for the test ampoules were converted to pmol ATP/100 μl using the fitted regression lines. The results were then converted to ng ATP/ampoule. The overall mean of laboratory means was calculated as the final estimate for the preparation for both the cultural viable count and modified ATP assays. An estimate of uncertainty combining the standard deviation (SD) of the mean (reflecting variability between laboratories) with the pooled laboratory SD (reflecting between-ampoule homogeneity and variability between assays) was used to calculate an expanded uncertainty corresponding to a 95% level of confidence.